Science F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. August 26, 2026 1 minute read Read More → Post navigation Previous: Door was locked at Pakistan hospital where fire killed 14 babies, witnesses sayNext: Actor Tim Curry has died Related Stories Science Top Mathematician Announces New Institute for A.I. Safety September 8, 2026 Science The 92-Year-Old Mathematician and the Teenage Apprentice September 6, 2026 Science Is There Alien Debris on the Moon? Some Scientists Plan to Find Out. September 5, 2026
